Statistics

Total Visits

Views
Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)35

Select a period of time:

Number of views in the range

Views
Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)19

Views

Views
January 20250
February 20250
March 202516
April 20252
May 20250
June 20251
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Spain1
Hong Kong1
United States1
 

Top cities views

Views
Council Bluffs1
Hong Kong1